share_log

Craig-Hallum Maintains Buy on Ironwood Pharmaceuticals, Lowers Price Target to $14

Craig-Hallum Maintains Buy on Ironwood Pharmaceuticals, Lowers Price Target to $14

Craig-Hallum維持對Ironwood Pharmicals的買入,將目標股價下調至14美元
Benzinga ·  05/10 12:26

Craig-Hallum analyst Chase Knickerbocker maintains Ironwood Pharmaceuticals (NASDAQ:IRWD) with a Buy and lowers the price target from $18 to $14.

Craig-Hallum分析師蔡斯·尼克博克維持艾恩伍德製藥公司(納斯達克股票代碼:IRWD)的買入並將目標股價從18美元下調至14美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論